Compound oral liquid for treating esophageal carcinoma and cardiac carcinoma dysphagia

A technology for dysphagia and oral liquid, which is applied to the compound oral liquid for dysphagia of cardia cancer, in the field of treatment of esophageal cancer, can solve the problems of dysphagia and dysphagia of cardia cancer, and achieves the effects of low price, good taste and easy availability.

Inactive Publication Date: 2016-11-16
HENAN UNIV OF CHINESE MEDICINE
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In view of the above situation, in order to solve the defects of the prior art, the purpose of the present invention is to provide a compound oral liquid for the treatment of dysphagia in esophageal cancer and cardia cancer, which can effectively solve the problem of dysphagia in esophageal cancer and cardia cancer.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0009] When the present invention is implemented, it can be made from the following raw materials: 70-230ml of mannitol injection with a volume concentration of 20%, 5-10ml of lidocaine hydrochloride injection with a volume concentration of 2%, racemic anisodamine hydrochloride injection Liquid 10-25mg and fresh lotus root juice 70-280ml, mix the above raw materials evenly, and serve.

Embodiment 2

[0011] When the present invention is implemented, it can also be made from the following raw materials: 40ml of mannitol injection with a volume concentration of 20%, 14ml of lidocaine hydrochloride injection with a volume concentration of 2%, 6mg of racemic anisodamine hydrochloride injection and Fresh lotus root juice 290ml, mix the above ingredients evenly, and serve.

Embodiment 3

[0013] When the present invention is implemented, it can also be made from the following raw materials: a volume concentration of 20% mannitol injection 140ml, a volume concentration of 2% lidocaine hydrochloride injection 9ml, racemic anisodamine hydrochloride injection 17mg and Fresh lotus root juice 165ml, mix the above ingredients evenly, and serve.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to compound oral liquid for effectively treating esophageal carcinoma and cardiac carcinoma dysphagia. According to the technical scheme, the compound oral liquid is prepared by evenly mixing 30-250ml of mannitol injection with the volume concentration being 20%, 3-15ml of lidocaine hydrochloride injection with the volume concentration being 2%, 5-30mg of racanisodamine hydrochloride injection and 30-300ml of fresh lotus root juice. The compound oral liquid is simple to prepare, easy in raw material obtaining, low in price, good in taste, convenient to take and evident in effect and is innovation of medicine for treating esophageal carcinoma and cardiac carcinoma dysphagia.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a compound oral liquid for treating dysphagia of esophageal cancer and cardia cancer. Background technique [0002] Esophageal cancer and cardia cancer are common malignant tumors in clinic. Due to the absence of significant clinical symptoms in the early stage, 60%-70% of patients have lost the chance of surgical resection at the time of diagnosis, and the 5-year survival rate is about 30%. The most prominent symptom of esophageal cancer is dysphagia. In mild cases, food infarction is not smooth, and in severe cases, a drop of water cannot be taken in, resulting in a sharp decline in the nutritional status and quality of life of patients. Clinically, chemotherapy, radiotherapy, esophageal stent placement, indwelling gastric tube, percutaneous gastrostomy and other methods are used for treatment. Although they have certain effects, they are often limited by the patient's age, disease sta...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/62A61P1/00A61P1/08A61K31/047A61K31/167A61K31/46
CPCA61K9/0095A61K31/047A61K31/167A61K31/46A61K36/62A61K2300/00
Inventor 韩倩倩王俊涛王白燕王守东晁丽琴孙宁朱艳琴李瑞琴杨联河石佳佳
Owner HENAN UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap